Allo-immunity and graft rejection after checkpoint inhibitor therapy (CPI) in solid organ transplant (SOT) recipients.

被引：1

作者：

Abdel-Wahab, Noha

Abudayyeh, Ala

Shah, Mohsin

Johnson, Daniel H.

VanAnh Trinh

Abdelrahim, Maen

Gaber, A. Osama

Suarez-Almazor, Maria E.

Diab, Adi

机构：

[1] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Houston Methodist, Houston, TX USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.3082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3082

引用

页数：1